| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $135.2M | +47.9% |
| R&D Expense | $222.5M | +0.9% |
| SG&A Expense | $67.2M | +8.7% |
| Operating Income | -$154.6M | +19.1% |
| Pre-tax Income | -$128.9M | +19.7% |
| Income Tax | -$6.6M | +50.8% |
| Net Income | -$122.3M | +16.8% |
| EPS (Basic) | -$2.27 | +17.8% |
| EPS (Diluted) | -$2.27 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $471.4M | -23.8% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $485.4M | -24.1% |
| Total Assets | $547.1M | -21.4% |
| Current Liabilities | $48.5M | -14.7% |
| Total Liabilities | $60.2M | -55.4% |
| Stockholders' Equity | $486.9M | -13.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$150.1M | -12.1% |
| Investing Cash Flow | -$298K | +89.3% |
| Financing Cash Flow | $1.6M | -96.6% |
| +17.8% |